Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
01/08/2008 | US7316913 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
01/08/2008 | US7316911 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
01/08/2008 | US7316900 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer |
01/08/2008 | US7316818 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
01/08/2008 | CA2439291C Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists |
01/08/2008 | CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
01/08/2008 | CA2408602C Phenylglycine derivatives |
01/08/2008 | CA2402668C Use of cdp-choline for the prophylactic treatment of cerebral ischemia |
01/08/2008 | CA2218145C Method of treating dilated cardiomyopathy |
01/07/2008 | CA2551578A1 Lignan complex derived from flax seed used for treatment of hypercholesterolemic atherosclerosis |
01/03/2008 | WO2008003028A2 Pharmaceutical compositions comprising droxidopa |
01/03/2008 | WO2008002905A2 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
01/03/2008 | WO2008002683A2 Polymorphous forms of carvedilol phosphate |
01/03/2008 | WO2008002576A2 Prolyl hydroxylase inhibitors and methods of use |
01/03/2008 | WO2008001959A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
01/03/2008 | WO2008001930A1 Pyridylisoxazole derivative |
01/03/2008 | WO2008001912A1 Substituted benzyl ester derivative and use thereof |
01/03/2008 | WO2008001884A1 Antiarteriosclerosis agents |
01/03/2008 | WO2008001883A1 α-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT |
01/03/2008 | WO2008001734A1 Compressed preparation |
01/03/2008 | WO2008001134A1 1,2,3,8,9,9a-hexahydro-7h-benzo(de)-1,7-naphthyridin-7-one derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
01/03/2008 | WO2008000968A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same |
01/03/2008 | WO2008000967A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same |
01/03/2008 | WO2008000951A2 Urea derivatives of tropane, their preparation and their therapeutic application |
01/03/2008 | WO2008000744A2 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor |
01/03/2008 | WO2008000186A1 A method for identifying novel gene and the resulting novel genes |
01/03/2008 | WO2008000166A1 Granule and preparation method thereof |
01/03/2008 | WO2008000040A1 A stabilised composition comprising ace inhibitors |
01/03/2008 | WO2007123984A3 Pre-mixed, ready-to-use pharmaceutical compositions |
01/03/2008 | WO2007120600A3 3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
01/03/2008 | WO2007117961A3 Renin inhibitors |
01/03/2008 | WO2006113942A3 Method of inhibiting cathepsin activity |
01/03/2008 | US20080004333 Ion channel modulating compounds and uses thereof |
01/03/2008 | US20080004322 Methods of food intake management |
01/03/2008 | US20080004318 Substituted Bicyclic and Tricyclic Thrombin Receptor Antagonists |
01/03/2008 | US20080004315 Guanidine Derivatives and Therapeutic Uses Thereof |
01/03/2008 | US20080004312 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
01/03/2008 | US20080004309 [(2-bromo-4-hydroxy-1-phenyl-1H-pyrrolo[2,3-c]pyridine-5-carbonyl)-amino]-acetic acid; modulates the stability and/or activity of hypoxia inducible factor (HIF) |
01/03/2008 | US20080004301 Benzene Compound Having 2 or More Substituents |
01/03/2008 | US20080004295 Novel compounds |
01/03/2008 | US20080004293 Adenosine receptor antagonists and methods of making and using the same |
01/03/2008 | US20080004262 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period |
01/03/2008 | US20080004257 Kinase inhibitors |
01/03/2008 | US20080004251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor |
01/03/2008 | US20080004210 Diagnostic markers for ischemia |
01/03/2008 | US20080004207 Use of hmgb1 for protection against ischemia reperfusion injury |
01/03/2008 | US20080003675 Methods and compositions for identifying morphogen analogs |
01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
01/03/2008 | US20080003285 Immediate Release Pharmaceutical Tablets With Height Greater Than Width |
01/03/2008 | US20080003269 Poncirus Trifoliata Extract for Preventing and Treating Ischemic Heart Diseases and Pharmaceutical Composition and Health Food Containing the Same |
01/03/2008 | US20080003266 Composition Comprising Statins |
01/03/2008 | US20080003254 Systems and methods for delivering a rapamycin analog that do not inhibit human coronary artery endothelial cell migration |
01/03/2008 | US20080003206 ABCB5 positive mesenchymal stem cells as immunomodulators |
01/03/2008 | US20080003199 IL-33 in the treatment and diagnosis of diseases and disorders |
01/03/2008 | US20080003179 Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis |
01/03/2008 | DE102006031314A1 Use of 1,4-diaryl-dihydropyrimidin-2-one derivative for producing a medicament for the treatment and/or prophylaxis of e.g. pulmonary arterial hypertension, chronic-obstructive lung diseases and sleep apnea syndrome |
01/03/2008 | CA2787343A1 Compositions comprising modified lcat and uses thereof |
01/03/2008 | CA2656159A1 Pyridylisoxazole derivatives |
01/03/2008 | CA2655913A1 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
01/03/2008 | CA2654986A1 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
01/03/2008 | CA2654414A1 Granule and preparation method thereof |
01/03/2008 | CA2654371A1 Therapeutic compounds |
01/03/2008 | CA2653382A1 A stabilised composition comprising ace inhibitors |
01/03/2008 | CA2648769A1 Urea derivatives of tropane, their preparation and their therapeutic application |
01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
01/02/2008 | EP1873154A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF |
01/02/2008 | EP1873153A1 Heterocyclic compound |
01/02/2008 | EP1873148A1 pharmaceutical compositions containing crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid |
01/02/2008 | EP1873140A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
01/02/2008 | EP1873139A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
01/02/2008 | EP1872797A2 Treatment of cardiovascular and related pathologies |
01/02/2008 | EP1872785A1 pharmaceutical composition comprising condensed indole compound |
01/02/2008 | EP1872782A1 Drug for treating or diagnosing vascular lesion in the skin or the subcutaneous soft tissue caused by light irradiation |
01/02/2008 | EP1871773A1 N-[3-(1-amino-5,6,7,8-tetrahydro-2,4,4b-triazafluoren-9-yl)-phenyl]benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
01/02/2008 | EP1871758A1 Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers |
01/02/2008 | EP1871398A1 Use of a biological active blood serum for the treatment of stroke |
01/02/2008 | EP1871392A1 Modulating angiogenesis with nod factors such as glucosamine oligosaccharides |
01/02/2008 | EP1871367A2 Compounds for treating inflammatory and demyelinating diseases |
01/02/2008 | EP1435986B1 Igf-binding protein-derived peptide |
01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
01/02/2008 | EP1406859B1 Substituted 4-aminocyclohexanol derivatives |
01/02/2008 | EP1381380B1 Pharmaceutical composition containing bulbophyllum |
01/02/2008 | EP1381376B1 Water-absorbent polymers and their use |
01/02/2008 | EP1268404B1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
01/02/2008 | EP1263739B1 Crystalline salts of 7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino pyrimidin-5-yl -(3r,5s)-3,5-dihydroxyhept-6-enoic acid |
01/02/2008 | EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
01/02/2008 | EP1121116B1 Sustained release pharmaceutical composition of fluvastatin |
01/02/2008 | EP1100870B1 Improvement of cardiac function by mesenchymal stem cell transplantation |
01/02/2008 | CN101098861A Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators |
01/02/2008 | CN101098709A Use of a trpc channel for the treatment of a cardiovascular disease |
01/02/2008 | CN101098702A Drugs, food or drink for improving pancreatic functions |
01/02/2008 | CN101098698A 5-carboxamido substitued thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family |
01/02/2008 | CN101098689A Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor |
01/02/2008 | CN101096363A 2,4,5-three-substituted thiazole compound, preparation method, medicament composition and pharmacy use thereof |
01/02/2008 | CN101096348A New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
01/02/2008 | CN101096347A New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
01/02/2008 | CN101096346A New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
01/02/2008 | CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
01/02/2008 | CN101095956A Scutellarin prodrug using carboxymethyl chitosan as the carrier and method for preparing the same |
01/02/2008 | CN101095955A Scutellarin prodrug using poly-aspartate derivant as the carrier and method for preparing the same |